Melatonin Contributes to the Seasonality of Multiple Sclerosis Relapses

Cell

Volumn 162, Issue 6, 2015, Pages 1338-1352

  Farez, Mauricio F ^a   Mascanfroni, Ivan D ^b   Méndez Huergo, Santiago P ^c   Yeste, Ada ^b   Murugaiyan, Gopal ^b   Garo, Lucien P ^b   Balbuena Aguirre, María E ^a,d   Patel, Bonny ^b   Ysrraelit, María C ^a   Zhu, Chen ^b   Kuchroo, Vijay K ^b   Rabinovich, Gabriel A ^c,e   Quintana, Francisco J ^b   Correale, Jorge ^a  

^a Instituto de Investigaciones Neurologicas Raul Carrera   (Argentina)

^b HARVARD MEDICAL SCHOOL   (United States)

^c Facultad de Ciencias Naturales e Instituto M Lillo   (Argentina)

^d HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^e UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; INTERLEUKIN 10; MELATONIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; RETINOID RELATED ORPHAN RECEPTOR ALPHA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NFIL3; UNCLASSIFIED DRUG; BASIC LEUCINE ZIPPER TRANSCRIPTION FACTOR; CCAAT ENHANCER BINDING PROTEIN;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTUMN; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ACTIVITY; ENZYME ACTIVATION; EXPERIMENTAL ALLERGIC ENCEPHALITIS; FEMALE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SEASONAL VARIATION; TH17 CELL; TRANSACTIVATION; WINTER; ANIMAL; C57BL MOUSE; CYTOLOGY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; IMMUNOLOGY; LIGHT; METABOLISM; PATHOLOGY; RECURRENT DISEASE; SEASON; SIGNAL TRANSDUCTION;

ANIMALS; BASIC-LEUCINE ZIPPER TRANSCRIPTION FACTORS; CCAAT-ENHANCER-BINDING PROTEINS; CELL DIFFERENTIATION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; HUMANS; LIGHT; MALE; MAP KINASE SIGNALING SYSTEM; MELATONIN; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; NUCLEAR RECEPTOR SUBFAMILY 1, GROUP F, MEMBER 3; RECURRENCE; SEASONS; T-LYMPHOCYTES, REGULATORY; TH17 CELLS;

EID: 84941361355     PISSN: 00928674     EISSN: 10974172     Source Type: Journal    
DOI: 10.1016/j.cell.2015.08.025     Document Type: Article

References (65)

1. L. Apetoh, F.J. Quintana, C. Pot, N. Joller, S. Xiao, D. Kumar, E.J. Burns, D.H. Sherr, H.L. Weiner, and V.K. Kuchroo The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27 Nat. Immunol. 11 2010 854 861
2. A. Ascherio, K.L. Munger, E.T. Lennette, D. Spiegelman, M.A. Hernán, M.J. Olek, S.E. Hankinson, and D.J. Hunter Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study JAMA 286 2001 3083 3088
3. A. Ascherio, K.L. Munger, and K.C. Simon Vitamin D and multiple sclerosis Lancet Neurol. 9 2010 599 612
4. A. Ascherio, K.L. Munger, and J.D. Lünemann The initiation and prevention of multiple sclerosis Nat. Rev. Neurol. 8 2012 602 612
5. A. Ascherio, K.L. Munger, R. White, K. Köchert, K.C. Simon, C.H. Polman, M.S. Freedman, H.-P. Hartung, D.H. Miller, X. Montalbán, and et al. Vitamin D as an early predictor of multiple sclerosis activity and progression JAMA Neurol. 71 2014 306 314
6. A.L. Astier, G. Meiffren, S. Freeman, and D.A. Hafler Alterations in CD46-mediated Tr1 regulatory T cells in patients with multiple sclerosis J. Clin. Invest. 116 2006 3252 3257
7. D.L. Baeten, and V.K. Kuchroo How Cytokine networks fuel inflammation: Interleukin-17 and a tale of two autoimmune diseases Nat. Med. 19 2013 824 825
8. A.H. Beecham, N.A. Patsopoulos, D.K. Xifara, M.F. Davis, A. Kemppinen, C. Cotsapas, T.S. Shah, C. Spencer, D. Booth, A. Goris, et al. International Multiple Sclerosis Genetics Consortium (IMSGC) Wellcome Trust Case Control Consortium 2 (WTCCC2) International IBD Genetics Consortium (IIBDGC) Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis Nat. Genet. 45 2013 1353 1360
9. A. Brzezinski Melatonin in humans N. Engl. J. Med. 336 1997 186 195
10. I. Castellano, E. Ercolesi, and A. Palumbo Nitric oxide affects ERK signaling through down-regulation of MAP kinase phosphatase levels during larval development of the ascidian Ciona intestinalis PLoS ONE 9 2014 e102907
11. L. Codarri, G. Gyülvészi, V. Tosevski, L. Hesske, A. Fontana, L. Magnenat, T. Suter, and B. Becher RORγt drives production of the cytokine GM-CSF in helper T cells, which is essential for the effector phase of autoimmune neuroinflammation Nat. Immunol. 12 2011 560 567
12. J. Correale, and M. Farez Association between parasite infection and immune responses in multiple sclerosis Ann. Neurol. 61 2007 97 108
13. J. Correale, M. Fiol, and W. Gilmore The risk of relapses in multiple sclerosis during systemic infections Neurology 67 2006 652 659
14. J. Correale, M.C. Ysrraelit, and M.I. Gaitán Immunomodulatory effects of Vitamin D in multiple sclerosis Brain 132 2009 1146 1160
15. M. El-Behi, B. Ciric, H. Dai, Y. Yan, M. Cullimore, F. Safavi, G.-X. Zhang, B.N. Dittel, and A. Rostami The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF Nat. Immunol. 12 2011 568 575
16. M.F. Farez, F.J. Quintana, R. Gandhi, G. Izquierdo, M. Lucas, and H.L. Weiner Toll-like receptor 2 and poly(ADP-ribose) polymerase 1 promote central nervous system neuroinflammation in progressive EAE Nat. Immunol. 10 2009 958 964
17. M.F. Farez, M.P. Fiol, M.I. Gaitan, F.J. Quintana, and J. Correale Sodium intake is associated with increased disease activity in multiple sclerosis J. Neurol. Neurosurg. Psychiatry 2014 10.1136/jnnp-2014-307928 Published online August 28, 2014
18. J. Fassi, M.F. Russo Picasso, A. Furci, P. Sorroche, R. Jáuregui, and L. Plantalech [Seasonal variations in 25-hydroxyvitamin D in young and elderly and populations in Buenos Aires City] Medicina (B. Aires) 63 2003 215 220
19. R. Gandhi, D. Kumar, E.J. Burns, M. Nadeau, B. Dake, A. Laroni, D. Kozoriz, H.L. Weiner, and F.J. Quintana Activation of the aryl hydrocarbon receptor induces human type 1 regulatory T cell-like and Foxp3(+) regulatory T cells Nat. Immunol. 11 2010 846 853
20. C. Graham, M.R. Cook, R. Kavet, A. Sastre, and D.K. Smith Prediction of nocturnal plasma melatonin from morning urinary measures J. Pineal Res. 24 1998 230 238
21. A.K. Hedström, T. Åkerstedt, J. Hillert, T. Olsson, and L. Alfredsson Shift work at young age is associated with increased risk for multiple sclerosis Ann. Neurol. 70 2011 733 741
22. M.A. Hernán, S.S. Jick, G. Logroscino, M.J. Olek, A. Ascherio, and H. Jick Cigarette smoking and the progression of multiple sclerosis Brain 128 2005 1461 1465
23. I.B. Hickie, and N.L. Rogers Novel melatonin-based therapies: potential advances in the treatment of major depression Lancet 378 2011 621 631
24. A.M. Jetten Retinoid-related orphan receptors (RORs): critical roles in development, immunity, circadian rhythm, and cellular metabolism Nucl. Recept. Signal. 7 2009 e003
25. Y. Jin, J. de Pedro-Cuesta, M. Söderström, L. Stawiarz, and H. Link Seasonal patterns in optic neuritis and multiple sclerosis: a meta-analysis J. Neurol. Sci. 181 2000 56 64
26. R. Jockers, P. Maurice, J.A. Boutin, and P. Delagrange Melatonin receptors, heterodimerization, signal transduction and binding sites: what's new? Br. J. Pharmacol. 154 2008 1182 1195
27. P.F. Johnson Molecular stop signs: regulation of cell-cycle arrest by C/EBP transcription factors J. Cell Sci. 118 2005 2545 2555
28. A. Karim, D. Tolbert, and C. Cao Disposition kinetics and tolerance of escalating single doses of ramelteon, a high-affinity MT1 and MT2 melatonin receptor agonist indicated for treatment of insomnia J. Clin. Pharmacol. 46 2006 140 148
29. T. Kobayashi, E.C. Steinbach, S.M. Russo, K. Matsuoka, T. Nochi, N. Maharshak, L.B. Borst, B. Hostager, J.V. Garcia-Martinez, P.B. Rothman, and et al. NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis J. Immunol. 192 2014 1918 1927
30. D.J. Kojetin, and T.P. Burris REV-ERB and ROR nuclear receptors as drug targets Nat. Rev. Drug Discov. 13 2014 197 216
31. T. Korn, E. Bettelli, M. Oukka, and V.K. Kuchroo IL-17 and Th17 Cells Annu. Rev. Immunol. 27 2009 485 517
32. S.K. Lathrop, S.M. Bloom, S.M. Rao, K. Nutsch, C.-W. Lio, N. Santacruz, D.A. Peterson, T.S. Stappenbeck, and C.-S. Hsieh Peripheral education of the immune system by colonic commensal microbiota Nature 478 2011 250 254
33. Y. Lee, A. Awasthi, N. Yosef, F.J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D.A. Hafler, and et al. Induction and molecular signature of pathogenic TH17 cells Nat. Immunol. 13 2012 991 999
34. J. Lekstrom-Himes, and K.G. Xanthopoulos Biological role of the CCAAT/enhancer-binding protein family of transcription factors J. Biol. Chem. 273 1998 28545 28548
35. K.I. Løken-Amsrud, T. Holmøy, S.J. Bakke, A.G. Beiske, K.S. Bjerve, B.T. Bjørnarå, H. Hovdal, F. Lilleås, R. Midgard, T. Pedersen, and et al. Vitamin D and disease activity in multiple sclerosis before and during interferon-β treatment Neurology 79 2012 267 273
36. M.M. Macchi, and J.N. Bruce Human pineal physiology and functional significance of melatonin Front. Neuroendocrinol. 25 2004 177 195
37. M.J. McGeachy, K.S. Bak-Jensen, Y. Chen, C.M. Tato, W. Blumenschein, T. McClanahan, and D.J. Cua TGF-β and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology Nat. Immunol. 8 2007 1390 1397
38. C.J. McMullan, E.S. Schernhammer, E.B. Rimm, F.B. Hu, and J.P. Forman Melatonin secretion and the incidence of type 2 diabetes JAMA 309 2013 1388 1396
39. P. Miossec, T. Korn, and V.K. Kuchroo Interleukin-17 and type 17 helper T cells N. Engl. J. Med. 361 2009 888 898
40. A.L. Morera, and P. Abreu Daytime/night-time and summer/winter melatonin and malondialdehyde rhythms: an inverse relationship J. Pineal Res. 43 2007 313 314
41. P. Pévet Melatonin: from seasonal to circadian signal J. Neuroendocrinol. 15 2003 422 426
42. C.H. Polman, S.C. Reingold, B. Banwell, M. Clanet, J.A. Cohen, M. Filippi, K. Fujihara, E. Havrdova, M. Hutchinson, L. Kappos, and et al. Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria Ann. Neurol. 69 2011 292 302
43. C. Pot, L. Apetoh, A. Awasthi, and V.K. Kuchroo Induction of regulatory Tr1 cells and inhibition of T(H)17 cells by IL-27 Semin. Immunol. 23 2011 438 445
44. D. Pozo, M. Delgado, J.M. Fernandez-Santos, J.R. Calvo, R.P. Gomariz, I. Martin-Lacave, G.G. Ortiz, and J.M. Guerrero Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen FASEB J. 11 1997 466 473
45. D. Pozo, S. García-Mauriño, J.M. Guerrero, and J.R. Calvo mRNA expression of nuclear receptor RZR/RORalpha, melatonin membrane receptor MT, and hydroxindole-O-methyltransferase in different populations of human immune cells J. Pineal Res. 37 2004 48 54
46. F.J. Quintana, A.S. Basso, A.H. Iglesias, T. Korn, M.F. Farez, E. Bettelli, M. Caccamo, M. Oukka, and H.L. Weiner Control of T(reg) and T(H)17 cell differentiation by the aryl hydrocarbon receptor Nature 453 2008 65 71
47. M.-G. Roncarolo, S. Gregori, M. Battaglia, R. Bacchetta, K. Fleischhauer, and M.K. Levings Interleukin-10-secreting type 1 regulatory T cells in rodents and humans Immunol. Rev. 212 2006 28 50
48. R. Rosecrans, and J.C. Dohnal Seasonal vitamin D changes and the impact on health risk assessment Clin. Biochem. 47 2014 670 672
49. T.F. Runia, W.C.J. Hop, Y.B. de Rijke, D. Buljevac, and R.Q. Hintzen Lower serum vitamin D levels are associated with a higher relapse risk in multiple sclerosis Neurology 79 2012 261 266
50. S. Sakaguchi, M. Miyara, C.M. Costantino, and D.A. Hafler FOXP3+ regulatory T cells in the human immune system Nat. Rev. Immunol. 10 2010 490 500
51. M. Saraiva, and A. O'Garra The regulation of IL-10 production by immune cells Nat. Rev. Immunol. 10 2010 170 181
52. M. Saraiva, J.R. Christensen, M. Veldhoen, T.L. Murphy, K.M. Murphy, and A. O'Garra Interleukin-10 production by Th1 cells requires interleukin-12-induced STAT4 transcription factor and ERK MAP kinase activation by high antigen dose Immunity 31 2009 209 219
53. S. Sawcer, G. Hellenthal, M. Pirinen, C.C.A. Spencer, N.A. Patsopoulos, L. Moutsianas, A. Dilthey, Z. Su, C. Freeman, S.E. Hunt, et al. International Multiple Sclerosis Genetics Consortium Wellcome Trust Case Control Consortium 2 Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis Nature 476 2011 214 219
54. E.S. Schernhammer, B. Rosner, W.C. Willett, F. Laden, G.A. Colditz, and S.E. Hankinson Epidemiology of urinary melatonin in women and its relation to other hormones and night work Cancer Epidemiol. Biomarkers Prev. 13 2004 936 943
55. S. Simpson Jr., B. Taylor, L. Blizzard, A.-L. Ponsonby, F. Pittas, H. Tremlett, T. Dwyer, P. Gies, and I. van der Mei Higher 25-hydroxyvitamin D is associated with lower relapse risk in multiple sclerosis Ann. Neurol. 68 2010 193 203
56. M. Sospedra, and R. Martin Immunology of multiple sclerosis Annu. Rev. Immunol. 23 2005 683 747
57. T. Spelman, O. Gray, M. Trojano, T. Petersen, G. Izquierdo, A. Lugaresi, R. Hupperts, R. Bergamaschi, P. Duquette, P. Grammond, and et al. Seasonal variation of relapse rate in multiple sclerosis is latitude dependent Ann. Neurol. 76 2014 880 890
58. L. Steinman Immunology of relapse and remission in multiple sclerosis Annu. Rev. Immunol. 32 2014 257 281
59. A.H.M. Tan, and K.P. Lam Pharmacologic inhibition of MEK-ERK signaling enhances Th17 differentiation J. Immunol. 184 2010 1849 1857
60. T. Ueno-Towatari, K. Norimatsu, K. Blazejczyk, H. Tokura, and T. Morita Seasonal variations of melatonin secretion in young females under natural and artificial light conditions in Fukuoka, Japan J. Physiol. Anthropol. 26 2007 209 215
61. V. Viglietta, C. Baecher-Allan, H.L. Weiner, and D.A. Hafler Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis J. Exp. Med. 199 2004 971 979
62. C. Wu, N. Yosef, T. Thalhamer, C. Zhu, S. Xiao, Y. Kishi, A. Regev, and V.K. Kuchroo Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1 Nature 496 2013 513 517
63. J. Yang, C.M. Croniger, J. Lekstrom-Himes, P. Zhang, M. Fenyus, D.G. Tenen, G.J. Darlington, and R.W. Hanson Metabolic response of mice to a postnatal ablation of CCAAT/enhancer-binding protein alpha J. Biol. Chem. 280 2005 38689 38699
64. X.O. Yang, B.P. Pappu, R. Nurieva, A. Akimzhanov, H.S. Kang, Y. Chung, L. Ma, B. Shah, A.D. Panopoulos, K.S. Schluns, and et al. T helper 17 lineage differentiation is programmed by orphan nuclear receptors ROR α and ROR γ Immunity 28 2008 29 39
65. X. Yu, D. Rollins, K.A. Ruhn, J.J. Stubblefield, C.B. Green, M. Kashiwada, P.B. Rothman, J.S. Takahashi, and L.V. Hooper TH17 cell differentiation is regulated by the circadian clock Science 342 2013 727 730